MENU
JDOC
ETF ticker: NASDAQ
PRICE
CHANGE
NET ASSETS

JDOC stock forecast, quote, news & analysis

The investment seeks to provide long-term capital appreciation... Show more

Category: #Health
JDOC
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
Interact to see
Advertisement
A.I.Advisor
a Summary for JDOC with price predictions
Jun 02, 2026

JDOC in upward trend: price rose above 50-day moving average on May 19, 2026

JDOC moved above its 50-day moving average on May 19, 2026 date and that indicates a change from a downward trend to an upward trend. In of 15 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on May 21, 2026. You may want to consider a long position or call options on JDOC as a result. In of 39 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for JDOC just turned positive on May 06, 2026. Looking at past instances where JDOC's MACD turned positive, the stock continued to rise in of 24 cases over the following month. The odds of a continued upward trend are .

The 10-day moving average for JDOC crossed bullishly above the 50-day moving average on May 18, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 5 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where JDOC advanced for three days, in of 99 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 139 cases where JDOC Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 29 cases where JDOC's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where JDOC declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), ABBVIE (NYSE:ABBV), Unitedhealth Group (NYSE:UNH), Merck & Co (NYSE:MRK), AstraZeneca PLC (NYSE:AZN), Amgen (NASDAQ:AMGN), Intuitive Surgical (NASDAQ:ISRG), CVS HEALTH Corp (NYSE:CVS), Bristol-Myers Squibb Co (NYSE:BMY).

Industry description

The investment seeks to provide long-term capital appreciation. The fund will invest primarily in equity securities issued by pharmaceutical, biotechnology, healthcare services, healthcare technology, medical technology and life sciences companies which the adviser believes are leaders and where the magnitude and/or duration of future growth for these companies is underappreciated by the market. Under normal circumstances, the fund invests at least 80% of its assets in the equity securities of healthcare companies.

Market Cap

The average market capitalization across the JPMorgan Healthcare Leaders ETF ETF is 88.68B. The market cap for tickers in the group ranges from 1.58B to 948.95B. LLY holds the highest valuation in this group at 948.95B. The lowest valued company is AGIO at 1.58B.

High and low price notable news

The average weekly price growth across all stocks in the JPMorgan Healthcare Leaders ETF ETF was 19%. For the same ETF, the average monthly price growth was 29%, and the average quarterly price growth was 124%. A experienced the highest price growth at 17%, while BSX experienced the biggest fall at -17%.

Volume

The average weekly volume growth across all stocks in the JPMorgan Healthcare Leaders ETF ETF was 9%. For the same stocks of the ETF, the average monthly volume growth was -6% and the average quarterly volume growth was 2%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 47
P/E Growth Rating: 56
Price Growth Rating: 51
SMR Rating: 62
Profit Risk Rating: 72
Seasonality Score: 27 (-100 ... +100)
View a ticker or compare two or three
JDOC
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category Health

Profile
Details
Category
Health
Address
J.P. Morgan Exchange-Traded Fund Trust390 Madison AvenueNew York
Phone
(844) 457-6383
Web
jpmorganfunds.com
JDOC in upward trend: price rose above 50-day moving average on May 19, 2026